Highest rheumatic heart disease deaths in India in 2015: Study

Image
Press Trust of India London
Last Updated : Aug 24 2017 | 8:42 PM IST
India accounted for the highest estimated number of deaths due to rheumatic heart disease globally in 2015 with over 119,000 people dying from the ailment, according to a study.
India was among the five countries with the largest estimated numbers of cases of rheumatic heart disease in 2015, together accounting for 73 per cent of global cases.
The number of cases of rheumatic heart disease in India were 13.17 million followed by China with 7.07 million, Pakistan with 2.25 million, Indonesia with 1.18 million, and the Democratic Republic of the Congo with 805,000, according to the study published in The New England Journal of Medicine.
"In 2015, the countries with the highest estimated numbers of deaths due to rheumatic heart disease were India (119,100 deaths), China (72,600), and Pakistan (18,900)," it said.
The highest estimated age-standardised death rates - more than 10 deaths per 100,000 population - were in the Solomon Islands, Pakistan, Papua New Guinea, Kiribati, Vanuatu, Fiji, India, Federated States of Micronesia, Marshall Islands, Central African Republic, and Lesotho, it added.
Rheumatic heart disease is a sequela of acute rheumatic fever, which is usually a disease of poverty associated with overcrowding, poor sanitation and other social determinants of poor health.
According to the study, global age-standardised mortality from rheumatic heart disease decreased from 9.2 deaths per 100,000 population in 1990 to 4.8 deaths per 100,000 population in 2015, a decrease of 47.8 per cent.
An estimated 77 per cent and 82 per cent of the deaths in 1990 and 2015, respectively, occurred in locations with an endemic disease pattern.
The study titled 'Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015' used multiple sources of data and epidemiological modelling techniques to estimate the global prevalence of and mortality due to rheumatic heart disease over a 25-year period.
The health-related burden of rheumatic heart disease has declined worldwide, but the condition persists in some of the poorest regions in the world, the study concluded.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 24 2017 | 8:42 PM IST

Next Story